article thumbnail

Magazine: Genomic projects exploit scale as clinical applications play catch-up

Pharmaceutical Technology

This month, we take a look at emerging research in this area , including that from the United Kingdom’s 100,000 Genomes Project, and understand how clinical applications could follow in the near future. You can also subscribe here to receive email notifications when a new issue is available.

article thumbnail

Open Source “Wikipedia” for Drug Discovery

Pharma Mirror

Open source drug discovery will allow more efficient, predicable, and cost-effective development of drugs that work as advertised, with fewer side effects. In 2003 the Human Genome Project provided the first atlas. The post Open Source “Wikipedia” for Drug Discovery appeared first on Pharma Mirror Magazine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

As the Smithsonian wraps a landmark genome exhibit, leaders in the field reflect on what’s changed

STAT News

When the Smithsonian National Museum of Natural History opened its genomics exhibit in 2013, the field was just celebrating the 10th anniversary of the completed Human Genome Project. Sequencing that first genome cost over $500 million. The genomes since cost $10,000. Read the rest…

article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates.

article thumbnail

The cluster effect: Connectivity and collaboration in life sciences hubs

Pharmaceutical Technology

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. We want to continue to facilitate the development of processes, technologies and strategies that produce real-world, beneficial impact for those that we serve.”. The city has listened.

article thumbnail

Realising the promise of genomic testing across oncology

pharmaphorum

Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world.

article thumbnail

Genomics England will move HQ to Canary Wharf’s new biocluster

pharmaphorum

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development.

Genomics 111